Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2021-05-06
DOI
10.1080/10428194.2021.1894652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells
- (2020) Ivetta Danylesko et al. LEUKEMIA
- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
- (2020) A. Hochhaus et al. LEUKEMIA
- Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
- (2020) Daniel W. Thomson et al. LEUKEMIA
- Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
- (2020) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
- (2020) Tun Kiat Ko et al. BLOOD
- Response and Resistance to BCR-ABL1-Targeted Therapies
- (2020) Theodore P. Braun et al. CANCER CELL
- Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
- (2020) Tobias Herold et al. LEUKEMIA
- High-risk additional chromosomal abnormalities at low blast counts herald death by CML
- (2020) Rüdiger Hehlmann et al. LEUKEMIA
- RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
- (2020) Shady Adnan Awad et al. LEUKEMIA
- Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
- (2020) Domenico Russo et al. Journal of Clinical Medicine
- De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
- (2019) Vera Magistroni et al. HAEMATOLOGICA
- RUNX1 targeted therapy for AML expressing somatic or germline mutation in RUNX1
- (2019) Christopher P Mill et al. BLOOD
- Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second generation tyrosine kinase inhibitors
- (2019) Georgios Nteliopoulos et al. HAEMATOLOGICA
- SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
- (2019) Yunzhu Dong et al. LEUKEMIA
- Chronic myeloid leukemia stem cells
- (2019) Mohammad Houshmand et al. LEUKEMIA
- T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
- (2019) Aude G. Chapuis et al. NATURE MEDICINE
- Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
- (2019) Fabien Muselli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A genome-wide DNA methylation signature for SETD1B-related syndrome
- (2019) I. M. Krzyzewska et al. Clinical Epigenetics
- Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
- (2019) Luana Bavaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Do persons with chronic myeloid leukaemia have normal or near normal survival?
- (2019) Tomas Radivoyevitch et al. LEUKEMIA
- Genetic Mutations in a Patient with Chronic Myeloid Leukemia Showing Blast Crisis 10 Years After Presentation
- (2018) LISA-MADELEINE SKLARZ et al. ANTICANCER RESEARCH
- Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease
- (2018) Susan Branford et al. BLOOD
- The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
- (2018) René Marke et al. HAEMATOLOGICA
- Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
- (2018) Thomas Ernst et al. LEUKEMIA
- BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients
- (2018) Hein Than et al. LEUKEMIA & LYMPHOMA
- Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study
- (2018) Ronan T. Swords et al. LEUKEMIA RESEARCH
- Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
- (2018) Bayley A. Jones et al. MOLECULAR CANCER THERAPEUTICS
- The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
- (2018) René Marke et al. HAEMATOLOGICA
- Acute myeloid leukemia: 2019 update on risk-stratification and management
- (2018) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
- (2018) Jong-Ho Park et al. LEUKEMIA
- Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis
- (2017) Leonardo Campiotti et al. EUROPEAN JOURNAL OF CANCER
- Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors
- (2017) Ami B. Patel et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Drug-perturbation-based stratification of blood cancer
- (2017) Sascha Dietrich et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
- (2017) E I Andersson et al. LEUKEMIA
- Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy
- (2017) TaeHyung Kim et al. LEUKEMIA RESEARCH
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
- (2017) E Togasaki et al. Blood Cancer Journal
- ASXL1andJAK2V617Fgene mutation screening in Iranian patients with chronic myeloid leukemia
- (2016) Amir Valikhani et al. Asia-Pacific Journal of Clinical Oncology
- Management of CML-blast crisis
- (2016) Rüdiger Hehlmann et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
- (2016) TaeHyung Kim et al. BLOOD
- Somatic mosaicism in chronic myeloid leukemia in remission
- (2016) K. Mitani et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Genetic and epigenetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia
- (2016) R. Rampal et al. HAEMATOLOGICA
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
- (2016) Hannah Bower et al. JOURNAL OF CLINICAL ONCOLOGY
- BCOR regulates myeloid cell proliferation and differentiation
- (2016) Q Cao et al. LEUKEMIA
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
- (2016) Jean Claude Chomel et al. Oncotarget
- SETD2: an epigenetic modifier with tumor suppressor functionality
- (2016) Jun Li et al. Oncotarget
- Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia
- (2016) R. Rampal et al. HAEMATOLOGICA
- Mutations in AML: prognostic and therapeutic implications
- (2016) C. D. DiNardo et al. Hematology-American Society of Hematology Education Program
- Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
- (2015) Alice Fabarius et al. ANNALS OF HEMATOLOGY
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia
- (2015) Michelle L. Churchman et al. CANCER CELL
- Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
- (2015) Simona Soverini et al. Clinical Lymphoma Myeloma & Leukemia
- Targeting EZH2 for Cancer Therapy: Progress and Perspective
- (2015) Chi Han Li et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis
- (2015) Wei Wang et al. Journal of Hematology & Oncology
- Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
- (2015) M Pfirrmann et al. LEUKEMIA
- Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
- (2015) Tea Pemovska et al. NATURE
- Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
- (2015) P O Pietarinen et al. Blood Cancer Journal
- Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian
- (2014) Jacqueline Mersch et al. CANCER
- Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase
- (2014) Bei Hu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Discovery of somatic mutations in the progression of chronic myeloid leukemia by whole-exome sequencing
- (2014) Y. Huang et al. GENETICS AND MOLECULAR RESEARCH
- Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
- (2014) M Schmidt et al. LEUKEMIA
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
- (2013) F. Damm et al. BLOOD
- Analysis of BCR/ABL transcripts in healthy individuals
- (2013) J.A. Boquett et al. GENETICS AND MOLECULAR RESEARCH
- RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib
- (2013) H Lilljebjörn et al. LEUKEMIA
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia
- (2013) Elias J. Jabbour et al. LEUKEMIA & LYMPHOMA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice
- (2013) Kiyoko Yamamoto et al. PLoS One
- A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib
- (2013) Vanessa Augis et al. PLoS One
- ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
- (2013) J Menezes et al. Blood Cancer Journal
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
- (2012) L.-J. Zhao et al. BLOOD
- Absence of DNMT3A gene mutation in chronic myeloid leukemia patients in blast crisis
- (2012) Xianmin Li et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability
- (2012) A Slupianek et al. LEUKEMIA
- A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
- (2012) King Pan Ng et al. NATURE MEDICINE
- CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
- (2011) H. Makishima et al. BLOOD
- Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
- (2011) J. Hasford et al. BLOOD
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Molecular Pathways: BCR-ABL
- (2011) D. Cilloni et al. CLINICAL CANCER RESEARCH
- The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia
- (2011) E. Tiacci et al. HAEMATOLOGICA
- Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
- (2011) Rüdiger Hehlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
- (2011) C Roche-Lestienne et al. LEUKEMIA
- Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts
- (2011) G Fuka et al. LEUKEMIA
- A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
- (2011) V Grossmann et al. LEUKEMIA
- Development of t(8;21) and RUNX1–RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression
- (2011) Vesna Najfeld et al. Cancer Genetics
- Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors
- (2011) Ronald L. Paquette et al. Cancer Genetics
- IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis
- (2010) S Soverini et al. LEUKEMIA
- BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia
- (2010) B A Burke et al. LEUKEMIA
- High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
- (2010) J Boultwood et al. LEUKEMIA
- Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors
- (2009) S. Soverini et al. BLOOD
- Principles of ubiquitin and SUMO modifications in DNA repair
- (2009) Steven Bergink et al. NATURE
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
- (2008) C. Roche-Lestienne et al. BLOOD
- BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
- (2008) M Koptyra et al. LEUKEMIA
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
- (2008) Charles G. Mullighan et al. NATURE
- Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
- (2008) S.-J. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started